AUTHOR=Li Lin 

TITLE=Disproportionate adverse event signals of selumetinib in neurofibromatosis type I: insights from FAERS

JOURNAL=Frontiers in Pharmacology

VOLUME=15

YEAR=2025

URL=https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2024.1454418

DOI=10.3389/fphar.2024.1454418

ISSN=1663-9812